Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia – effects of selective inducible nitric oxide synthase inhibition

Summary

Coagulation abnormalities have been implicated in the pathogenesis of sepsis and organ dysfunction. Nitric oxide (NO) is regarded as a critical mediator of many vascular pathologies, including sepsis. However, limited evidence is available to document a relationship between NO generated by inducible NO synthase (iNOS) and hemostatic abnormalities in sepsis. Therefore, we evaluated the effects of selective iNOS inhibition on markers of endothelial and coagulation homeostasis in a clinically relevant model of porcine bacteremia induced and maintained for 24 hours (h) with a continuous infusion of live P. aeruginosa. After 12 h of sepsis, animals received either vehicle (Control, n = 7) or continuous infusion of selective iNOS inhibitor L-NIL (n=7). Before as well as 12, 18 and 24 h after starting P. aeruginosafollowing variables related to i) endothelial dysfunction (von Willebrand factor [vWf]; tissue plasminogen activator activity [t-PA]; ii) coagulation (thrombin-antithrombin complexes [TAT]; platelet count); iii) fibrinolysis (t-PA activity, activity of plasminogen activator inhibitor type 1 (PAI-1 act); and iv) oxidative/ nitrosative stress (isoprostanes, nitrate/nitrite levels) were measured. L-NIL inhibited sepsis-induced increase in plasma nitrate/nitrite and isoprostanes concentrations, prevented hypotension and acidosis. L-NIL significantly attenuated sepsisinduced rise in plasma vWF and TAT. P. aeruginosa-induced drop in t-PA activity was blunted by iNOS inhibition, while increased PAI-1 and reduced platelet count were not reversed by the treatment. In conclusion, selective iNOS inhibition was associated with attenuation of sepsis-induced coagulation and endothelial dysfunction suggesting the interplay between mediators of vascular system and hemostatic balance. Reduction of oxidative stress probably contributes to the beneficial effects afforded by iNOS blockade.

Keywords

Coagulation - DIC - nitric oxide - oxidative stress - sepsis

Footnote:

The work was performed at the Intensive Care Unit of the 1^st Medical Dept., Charles University Medical School and Teaching Hospital Plzen, Czech Republic.

• References

• 1 Singh S, Evans TW. Organ dysfunction during sepsis. Intensive Care Med 2006; 32: 349-360.
• 2 Wiel E, Vallet B, ten Cate H. The endothelium in intensive care. Crit Care Clin 2005; 21: 403-416.
• 3 Hack CE, Zeerleder S. The endothelium in sepsis: source of and target for inflammation. Crit Care Med 2001; 29 (Suppl) S21-S27.
• 4 Vincent JL. Microvascular endothelial dysfunction: renewed appreciation of sepsis pathophysiology. Crit Care 2001; 5: S1-S5.
• 5 Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-592.
• 6 Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med 2004; 30: 1032-1040.
• 7 Aird WC. Sepsis and coagulation. Crit Care Clin 2005; 21: 417-431.
• 8 Gando S, Nanzaki S, Sasaki S. et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26: 2005-2009.
• 9 Levi M, van der Poll T, ten Cate H. et al. The cytokine mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxemia. Eur J Clin Invest 1997; 27: 3-9.
• 10 Salvemini D, Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002; 33: 1173-1185.
• 11 Hauser B, Bracht H, Matejovic M. et al. Nitric oxide inhibition in sepsis? Lessons learned from largeanimal studies. Anesth Analg 2005; 101: 488-498.
• 12 Matejovic M, Radermacher P, Tugtekin I. et al. Effects of selective iNOS inhibition on gut and liver O2 – exchange and energy metabolism during hyperdynamic porcine endotoxemia. Shock 2001; 16: 203-210.
• 13 Matejovic M, Krouzecky A, Martinkova V. et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004; 21: 458-465.
• 14 Asakura H, Asamura R, Ontachi Y. et al. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats. J Thromb Haemost 2005; 3: 1050-1055.
• 15 Korbut R, Warner TD, Gryglewski RJ. et al. The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats. Br J Pharmacol 1994; 112: 289-291.
• 16 Gebhard F, Riepl C, Liener UC. et al. Volume replacement in trauma patients within the first 24 h and its impact on the interpretation of biochemical data. Langenbecks Arch Surg 2002; 385: 406-411.
• 17 Kang KW, Choi SY, Cho MK. et al. Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation. J Biol Chem 2003; 278: 17368-17378.
• 18 Taylor FB, Kinasewitz G. Activated protein C in sepsis. J Thromb Haemost 2004; 2: 708-717.
• 19 Isobe H, Okajima K, Uchiba M. et al. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001; 104: 1171-1175.
• 20 Radomski MW. The role of nitric oxide in vascular haemostasis and thrombosis: implications for septicaemia and cell damage. In: Schlag G, Redl H (eds.). Shock, sepsis and organ failure – nitric oxide. Springer- Verlag Berlin Heidelberg. 1995: 180-197.
• 21 Cerwinka WH, Cooper D, Krieglstein CF. et al. Nitric oxide modulates endotoxin-induced plateletendothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 2002; 282: H1111-H1117.
• 22 Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
• 23 Jourdain M, Tournoys A, Leroy X. et al. Effects of N omega-nitro-L-arginine methyl ester on the endotoxininduced disseminated intravascular coagulation in porcine septic shock. Crit Care Med 1997; 25: 452-459.
• 24 Kim SS, Hwang JH, Choi CW. et al. Detrimental effects of N(omega) nitro-L-arginine methyl ester (L-NAME) in experimental Escherichia coli sepsis in the newborn piglet. J Korean Med Sci 2003; 18: 637-640.
• 25 Ovechkin AV, Lominadze D, Sedoris KC. et al. Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol 2005; 99: 2423-2432.
• 26 Javesghani D, Hussain SN, Scheidel J. et al. Superoxide production in the vasculature of lipopolysaccharide- treated rats and pigs. Shock 2003; 19: 486-493.
• 27 Nielsen VG, Crow JP, Zhou F. et al. Peroxynitrite inactivates tissue plasminogen activator. Anesth Analg 2004; 98: 1312-1317.
• 28 Kutzsche S, Schlichting E, Aspelin T. et al. Hemodynamic changes and systemic activation of coagulation and fibrinolysis during controlled endotoxemia in pigs. Thromb Res 2000; 98: 517-529.
• 29 Trager K, Radermacher P, Rieger KM. et al. Norepinephrine and N(G)-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exchange and energy balance. Am J Respir Crit Care Med 1999; 159: 1758-1765.
• 30 Rosselet A, Feihl F, Markert M. et al. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 1998; 157: 162-170.